View Article

Abstract

Uterus didelphys is a rare congenital Müllerian duct anomaly characterized by complete duplication of the uterus and cervix. It is often asymptomatic and may remain undiagnosed until pregnancy or evaluation for reproductive concerns. We report the case of a 33-year-old primigravida who presented at 3 weeks of gestation for routine antenatal evaluation. First trimester obstetric ultrasonography revealed two completely separate uterine cavities with two distinct cervices, confirming the diagnosis of uterus didelphys. The patient had no prior history of abortion or significant drug exposure. She was managed conservatively with folic acid and progesterone supplementation and was counselled regarding potential obstetric risks, including preterm birth, fetal growth restriction, and the possibility of cesarean delivery. Early diagnosis and appropriate antenatal care are essential in optimizing maternal and fetal outcomes in such cases.

Keywords

Uterus didelphys, Müllerian anomaly, primigravida, pregnancy, congenital uterine anomaly

Introduction

Congenital uterine anomalies arise due to abnormal development, fusion, or resorption of the Müllerian ducts during embryogenesis. Uterus didelphys is a rare anomaly resulting from complete non-fusion of the Müllerian ducts, leading to duplication of the uterine horns and cervices.

Although many women remain asymptomatic, this condition is associated with adverse reproductive outcomes such as recurrent pregnancy loss, preterm labor, malpresentation, and increased cesarean section rates. Early detection during pregnancy plays a crucial role in risk stratification and management. This case highlights the incidental diagnosis of uterus didelphys in a primigravida during early pregnancy.

Case Presentation

A 33-year-old female presented to the obstetrics outpatient department with a history of missed menstrual period with LMP 06.12.25 and confirmed early pregnancy of approximately 3 weeks. This was her first pregnancy (primigravida).

She had no history of previous abortions, infertility, or menstrual irregularities. There was no significant past medical or surgical history. The patient also denied any history of chronic medication use, teratogenic drug exposure, smoking, or alcohol intake.

On general physical examination, the patient was stable, and vital parameters were within normal limits. Systemic examination revealed no abnormalities.

Investigations

Laboratory parameters done which include Hb, Differential Count, LFT, RFT, URE, Blood grouping, Thyroid profile.

First trimester obstetric ultrasound scan was performed, which revealed:

o     Presence of two completely separate uterine bodies

o     Two distinct endometrial cavities

o     Two cervices, confirming duplication

o     Early intrauterine pregnancy noted

o     These findings were consistent with a diagnosis of uterus didelphys

 

 

 

 

 

 

 

Management

 

The patient was managed conservatively with:

Folic acid supplementation to support fetal development

Progesterone therapy to support early pregnancy

In addition to pharmacological management, detailed counselling was provided regarding her condition.

Patient Counselling

The patient was educated about uterus didelphys and its implications on pregnancy. She was informed about potential risks, including:

Preterm labor and premature birth

Fetal growth restriction

Malpresentation

Increased likelihood of emergency cesarean section

Need for close antenatal monitoring

The importance of regular follow-up and adherence to medical advice was emphasized.

 

Outcome and Follow-up

At the time of reporting, the patient is under regular antenatal follow-up. She is stable, compliant with medications, and undergoing periodic monitoring to assess fetal growth and pregnancy progression.

DISCUSSION

Uterus didelphys is a rare congenital Müllerian duct anomaly resulting from complete non-fusion of the paired Müllerian ducts during embryological development. This leads to the formation of two separate uterine cavities, each with its own cervix, and occasionally a longitudinal vaginal septum. Reported prevalence ranges between 0.1% and 0.5% in the general female population, making it an uncommon but clinically significant condition.

Several studies have demonstrated that women with uterus didelphys may have relatively preserved fertility compared to other Müllerian anomalies; however, they are at increased risk for adverse obstetric outcomes. According to studies by Heinonen and colleagues, reproductive performance in such patients is often associated with complications such as preterm labor, malpresentation, and increased cesarean section rates. Similarly, Rackow and Arici reported that uterine anomalies, including uterus didelphys, are linked to higher incidences of fetal growth restriction and pregnancy loss, although many patients can still achieve successful pregnancies with appropriate care.

Early diagnosis plays a crucial role in optimizing pregnancy outcomes. Imaging modalities such as ultrasonography and magnetic resonance imaging (MRI) are commonly used to identify structural anomalies. In the present case, the diagnosis was made incidentally during a first trimester obstetric scan, which is consistent with previous reports where many cases remain undetected until pregnancy or evaluation for infertility.

Management of uterus didelphys during pregnancy is generally conservative, focusing on close antenatal surveillance rather than surgical correction. Progesterone supplementation, as given in this case, is often used to support early pregnancy, although its routine use depends on clinical judgment. Regular monitoring is essential to detect complications such as preterm labor or fetal growth abnormalities at an early stage.

Patient counselling is a critical component of management. Women should be informed about potential risks, including premature delivery, malpresentation, and the likelihood of operative delivery. However, it is equally important to reassure patients that favorable outcomes are achievable with proper antenatal care, as supported by multiple case series in the literature.

This case aligns with previously reported findings, demonstrating that uterus didelphys can be incidentally diagnosed in a primigravida with no prior reproductive complications. It underscores the importance of routine antenatal imaging and individualized patient management to ensure optimal maternal and fetal outcomes.

CONCLUSION

Uterus didelphys is a rare congenital anomaly that may remain undetected until pregnancy. Early diagnosis through routine antenatal imaging allows for appropriate counselling and careful monitoring to minimize adverse outcomes. With proper management, favorable maternal and fetal outcomes can be achieved.

REFERENCES

  1. Heinonen PK. Uterus didelphys: a report of 26 cases. Eur J Obstet Gynecol Reprod Biol. 1984;17:345–50.
  2. Acién P. Incidence of Müllerian defects in fertile and infertile women. Hum Reprod. 1997;12:1372–6.
  3. Acién P, Acién MI. The history of female genital tract malformation classifications. Hum Reprod Update. 2011;17:693–705.
  4. Rackow BW, Arici A. Reproductive performance of women with Müllerian anomalies. Curr Opin Obstet Gynecol. 2007;19:229–37.
  5. Grimbizis GF, et al. The classification of uterine congenital anomalies. Hum Reprod Update. 2013;19:1–15.
  6. Chandler TM, et al. Müllerian duct anomalies: from diagnosis to intervention. Br J Radiol. 2009;82:1034–42.
  7. Buttram VC Jr, Gibbons WE. Müllerian anomalies: a proposed classification. Fertil Steril. 1979;32:40–6.
  8. American Society for Reproductive Medicine. Uterine septum: guideline. Fertil Steril. 2016;106:530–40.
  9. Vercellini P, et al. Congenital uterine anomalies and reproductive outcomes. Hum Reprod. 2007;22:123–30.
  10. Saravelos SH, et al. Prevalence and diagnosis of congenital uterine anomalies. Hum Reprod Update. 2008;14:415–29.
  11. Hua M, et al. Congenital uterine anomalies and adverse pregnancy outcomes. Am J Obstet Gynecol. 2011;205:558.e1–5.
  12. Reichman D, et al. Pregnancy outcomes in unicornuate and didelphic uterus. Fertil Steril. 2009;91:1883–8.
  13. Raga F, et al. Reproductive impact of congenital Müllerian anomalies. Hum Reprod. 1997;12:2277–81.
  14. Lin PC. Reproductive outcomes in women with uterine anomalies. J Womens Health. 2004;13:33–9.
  15. Grigoris F, et al. Clinical management of uterus didelphys. Obstet Gynecol Int. 2012;2012:1–6.
  16. Nahum GG. Uterine anomalies: how common are they? Fertil Steril. 1998;70:1–6.
  17. Troiano RN, McCarthy SM. Müllerian duct anomalies: imaging and diagnosis. Radiology. 2004;233:19–34.
  18. Bermejo C, et al. Three-dimensional ultrasound in diagnosis of uterine anomalies. Ultrasound Obstet Gynecol. 2010;35:593–601.
  19. Rock JA, Schlaff WD. The obstetric consequences of uterovaginal anomalies. Fertil Steril. 1985;43:681–92.
  20. Saleh F, et al. Vaginal bleeding in a newborn as initial presentation of uterus didelphys. BMJ Case Rep. 2023.
  21. Hiratsuka D, et al. Interval vaginal delivery of twins in uterus didelphys. J Obstet Gynaecol Res. 2026.
  22. Sinha P, et al. Uterus didelphys in nulliparous and multiparous women. Asian J Pharm Clin Res. 2022.
  23. Gaillard F, et al. Uterus didelphys. Radiopaedia.org. 2025.
  24. Skondras KG, et al. Uterus didelphys with obstructed hemivagina. J Pediatr Surg. 1991.
  25. Kang J, Qiao J. Impact of congenital uterine anomalies on reproductive outcomes. Eur J Med Res. 2024.

Reference

  1. Heinonen PK. Uterus didelphys: a report of 26 cases. Eur J Obstet Gynecol Reprod Biol. 1984;17:345–50.
  2. Acién P. Incidence of Müllerian defects in fertile and infertile women. Hum Reprod. 1997;12:1372–6.
  3. Acién P, Acién MI. The history of female genital tract malformation classifications. Hum Reprod Update. 2011;17:693–705.
  4. Rackow BW, Arici A. Reproductive performance of women with Müllerian anomalies. Curr Opin Obstet Gynecol. 2007;19:229–37.
  5. Grimbizis GF, et al. The classification of uterine congenital anomalies. Hum Reprod Update. 2013;19:1–15.
  6. Chandler TM, et al. Müllerian duct anomalies: from diagnosis to intervention. Br J Radiol. 2009;82:1034–42.
  7. Buttram VC Jr, Gibbons WE. Müllerian anomalies: a proposed classification. Fertil Steril. 1979;32:40–6.
  8. American Society for Reproductive Medicine. Uterine septum: guideline. Fertil Steril. 2016;106:530–40.
  9. Vercellini P, et al. Congenital uterine anomalies and reproductive outcomes. Hum Reprod. 2007;22:123–30.
  10. Saravelos SH, et al. Prevalence and diagnosis of congenital uterine anomalies. Hum Reprod Update. 2008;14:415–29.
  11. Hua M, et al. Congenital uterine anomalies and adverse pregnancy outcomes. Am J Obstet Gynecol. 2011;205:558.e1–5.
  12. Reichman D, et al. Pregnancy outcomes in unicornuate and didelphic uterus. Fertil Steril. 2009;91:1883–8.
  13. Raga F, et al. Reproductive impact of congenital Müllerian anomalies. Hum Reprod. 1997;12:2277–81.
  14. Lin PC. Reproductive outcomes in women with uterine anomalies. J Womens Health. 2004;13:33–9.
  15. Grigoris F, et al. Clinical management of uterus didelphys. Obstet Gynecol Int. 2012;2012:1–6.
  16. Nahum GG. Uterine anomalies: how common are they? Fertil Steril. 1998;70:1–6.
  17. Troiano RN, McCarthy SM. Müllerian duct anomalies: imaging and diagnosis. Radiology. 2004;233:19–34.
  18. Bermejo C, et al. Three-dimensional ultrasound in diagnosis of uterine anomalies. Ultrasound Obstet Gynecol. 2010;35:593–601.
  19. Rock JA, Schlaff WD. The obstetric consequences of uterovaginal anomalies. Fertil Steril. 1985;43:681–92.
  20. Saleh F, et al. Vaginal bleeding in a newborn as initial presentation of uterus didelphys. BMJ Case Rep. 2023.
  21. Hiratsuka D, et al. Interval vaginal delivery of twins in uterus didelphys. J Obstet Gynaecol Res. 2026.
  22. Sinha P, et al. Uterus didelphys in nulliparous and multiparous women. Asian J Pharm Clin Res. 2022.
  23. Gaillard F, et al. Uterus didelphys. Radiopaedia.org. 2025.
  24. Skondras KG, et al. Uterus didelphys with obstructed hemivagina. J Pediatr Surg. 1991.
  25. Kang J, Qiao J. Impact of congenital uterine anomalies on reproductive outcomes. Eur J Med Res. 2024.

Photo
Drishya L.
Corresponding author

Assisstant Professor, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, TVM, Kerala

Photo
Amritha Krishna
Co-author

Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, TVM, Kerala

Photo
Jeffnisha J.
Co-author

Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, TVM, Kerala

Photo
Shaiju Dharan
Co-author

Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, TVM, Kerala

Amritha Krishna, Jeffnisha J., Drishya L., Shaiju Dharan, A Rare Case of Uterus Didelphys Diagnosed in a Primigravida Woman, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 4, 4263-4367, https://doi.org/10.5281/zenodo.19786192

More related articles
AI-Designed Protein-Lipid Hybrid Nanoparticles for...
V R Teja Sruthi Pagadala, P. Rithisha, S K Asma, Hasrat Mirza, P....
A Review On Anti-Diabetic Effect Of Neem (Azadirac...
Yogita Dhuri , Vishal Biswas, Shamili Singh, Shruti Rathore, Divy...
Comparative Anthelmintic Potential Study of Aqueou...
Khomendra Sarwa, Manisha Chandrakar, Gaurav Kashyap, Rahul Singh,...
Related Articles
The Health Benefits of Dihydroberberine 100 mg Capsules: A Review...
Achal Agarwal, Pankaj Pillewan, Manik Chaudhuri, Girisha Maheshwari, ...
A Comprehensive Review on Analyzing Adverse Drug Reactions and Stability Profile...
Kaushal Chavan, Yogeshwar Chaudhari, Kiran Rathod, Dipali Chaudhari, Snehal Patil, Vishal Patil, ...
Development and Validation of New Analytical Methods for Assay of Bioactive Mole...
Ch. Devadas, D. Sarojini, Ch. Hemalatha, K. Venkatesh, B. Sowmya, D. Steeven Babu, ...
AI-Designed Protein-Lipid Hybrid Nanoparticles for Targeted Cancer Therapy and M...
V R Teja Sruthi Pagadala, P. Rithisha, S K Asma, Hasrat Mirza, P. Niveditha Spurthi, B. Rohini, L. G...
More related articles
AI-Designed Protein-Lipid Hybrid Nanoparticles for Targeted Cancer Therapy and M...
V R Teja Sruthi Pagadala, P. Rithisha, S K Asma, Hasrat Mirza, P. Niveditha Spurthi, B. Rohini, L. G...
A Review On Anti-Diabetic Effect Of Neem (Azadirachta Indica) Leaves...
Yogita Dhuri , Vishal Biswas, Shamili Singh, Shruti Rathore, Divyani Soni, ...
Comparative Anthelmintic Potential Study of Aqueous and Ethanolic Extracts of Le...
Khomendra Sarwa, Manisha Chandrakar, Gaurav Kashyap, Rahul Singh, Vijendra Kumar Suryawanshi, Varsha...
AI-Designed Protein-Lipid Hybrid Nanoparticles for Targeted Cancer Therapy and M...
V R Teja Sruthi Pagadala, P. Rithisha, S K Asma, Hasrat Mirza, P. Niveditha Spurthi, B. Rohini, L. G...
A Review On Anti-Diabetic Effect Of Neem (Azadirachta Indica) Leaves...
Yogita Dhuri , Vishal Biswas, Shamili Singh, Shruti Rathore, Divyani Soni, ...
Comparative Anthelmintic Potential Study of Aqueous and Ethanolic Extracts of Le...
Khomendra Sarwa, Manisha Chandrakar, Gaurav Kashyap, Rahul Singh, Vijendra Kumar Suryawanshi, Varsha...